IO Account Executive at Bristol-Myers Squibb

Zhengzhou, China

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Bachelor's degree or above in pharmaceutical, life sciences, or related field
1-3 years of sales experience in local hospital promotion
Oncology experience preferred
Strong interpersonal communication skills
Team collaboration spirit
Ability to independently analyze and solve problems
Ability to work under pressure

Responsibilities

Possess in-depth product knowledge and disease area knowledge
Achieve/exceed regional targets
Execute market strategies outlined by the market manager
Identify target HCPs from appropriate market segments and collaborate to achieve promotion plans
Fully understand key HCPs in the local region and responsible area
Update customer data
Coordinate local "hospital meetings."
Timely update HCP information and conduct visits according to plan
Establish and maintain relationships with key HCPs, understand customer (medical) needs
Achieve and maintain company requirements on visit frequency, knowledge level, capabilities, behavior, and personal image
Regularly (daily) report visit situations in the ETMS system
Provide accurate reports and contact direct supervisor according to specified processes
Provide feedback to direct supervisor on the effectiveness of BMS promotional materials
Develop and enhance professional knowledge through training, conferences, and self-study of medical literature; share knowledge and experience with team members
Manage professional equipment and promotional materials, ensuring they are in good condition

Skills

Pharmaceutical Sales

Immuno-Oncology

Oncology

HCP Engagement

Territory Management

Market Strategy

Sales Reporting

CRM Systems

Team Collaboration

Problem Solving

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free